|
|
| | Pantoprazole EP Impurity F Basic information |
| Product Name: | Pantoprazole EP Impurity F | | Synonyms: | 6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-3-methyl -1H-benzimidazole;Pantoprazole Impurity 30(Pantoprazole EP Impurity F);Pantoprazole impurity 3/Pantoprazole EP Impurity F/6-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole;6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1-methylbenzimidazole;Pantoprazole-4;Pantoprazole related compound F;Pantoprazole Ep Imp F;1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl- | | CAS: | 721924-06-7 | | MF: | C17H17F2N3O4S | | MW: | 397.4 | | EINECS: | | | Product Categories: | | | Mol File: | 721924-06-7.mol |  |
| | Pantoprazole EP Impurity F Chemical Properties |
| solubility | DMSO (Slightly, Sonicated), Methanol (Slightly) | | form | Solid | | color | Light Yellow to Light Beige |
| | Pantoprazole EP Impurity F Usage And Synthesis |
| Uses | 6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-benzimidazole was used in the study of chemistry of covalent inhibition of gastric ATPase by proton pump inhibitors. |
| | Pantoprazole EP Impurity F Preparation Products And Raw materials |
|